Statistical interaction in the survival analysis of early breast cancer using registry data: Role of breast conserving surgery and radiotherapy

Tumori

Volumn 91, Issue 1, 2005, Pages 9-14

  Vinh Hung, Vincent ^a,c   Burzykowski, Tomasz ^b   Van De Steene, Jan ^a   Voordeckers, Mia ^a   Lamote, Jan ^a   Storme, Guy ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Interaction; Prognostic factor; SEER program; Subgroup analysis

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST SURGERY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD; OUTCOMES RESEARCH; POSTOPERATIVE CARE; STATISTICAL ANALYSIS; STATISTICAL MODEL; SURGICAL TECHNIQUE; SURVIVAL RATE;

EID: 13244250676     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160509100103     Document Type: Article

References (30)

1. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CM, Paradis M, Goldman AJ, Olivotto IA: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med, 337: 956-962, 1997.
2. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K: Postoperative radiotherapy in high-risk pre-menopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med, 337: 949-955, 1997.
3. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet, 353: 1641-1648, 1999.
4. Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML: Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol, 18: 1220-1229, 2000.
5. Vinh-Hung V, Burzykowski T, Van de Steene J, Storme G, Soete G: Post-surgery radiation in early breast cancer, survival analysis of registry data. Radiother Oncol, 64: 281-290, 2002.
6. Vinh-Hung V, Verschraegen C: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst, 96: 115-121, 2004.
7. Vallis KA, Tannock IF: Postoperative radiotherapy for breast cancer: growing evidence for an impact on survival. J Natl Cancer Inst, 96: 88-89, 2004.
8. Van de Steene J, Vinh-Hung V, Cutuli B, Storme G: Adjuvant radiotherapy for breast cancer: effects of longer follow-up. Radiother Oncol, 72: 35-43, 2004.
9. Early Breast Cancer Trialists' Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet, 355: 1757-1770, 2000.
10. Atkins CD: Breast cancer survival advantage with radiotherapy. Lancet, 356: 1269, 2000.
11. Overgaard J, Bartelink H: Breast cancer survival advantage with radiotherapy. Lancet, 356: 1269-1270, 2000.
12. Ragaz J, Spinelli JJ, Coldman AJ: Breast cancer survival advantage with radiotherapy. Lancet, 356: 1270, 2000.
13. EBCTCG Secretariat: Breast cancer survival advantage with radiotherapy. Lancet, 356: 1271, 2000.
14. Veronesi U, Gatti G, Luini A, Intra M, Ciocca M, Sanchez D, Zurrida S, Navarro S, Orecchia R: Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg, 138: 1253-1256, 2003.
15. Intra M, Orecchia R, Veronesi U: Intraoperative radiotherapy: the debate continues. Lancet Oncol, 5: 340, 2004.
16. Morris AD, Morris RD, Wilson JF, White J, Steinberg S, Okunieff P, Arriagada R, Le MG, Blichert-Toft M, van Dongen JA: Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am. 3: 6-12, 1997.
17. Haffty BG, Ward BA: Is breast-conserving surgery with radiation superior to mastectomy in selected patients? Cancer J Sci Am, 3: 2-3, 1997.
18. National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-1998), National Cancer Institute, DCCPS, Cancer Surveillance Research Program, Cancer Statistics Branch, released April 2001. based on the August 2000 submission. 2001.
19. Cox DR: Regression models and life-tables. J R Stat Soc B. 34: 187-220, 1972.
20. Sauer R, Schulz KD, Hellriegel KP: Radiation therapy after mastectomy - interdisciplinary consensus puts and end to a controversy. German Society of Senology. Strahlenther Onkol, 177: 1-9, 2001.
21. Therneau TM, Grambsch PM: Modeling survival data: extending the Cox model, pp 39-185, Springer-Verlas. New York, 2000.
22. Vinh-Hung V, Voordeckers M, Van de Steene J, Soete G, Lamote J, Storme G: Omission of radiotherapy after breast-conserving surgery: survival impact and time trends. Radiother Oncol. 67: 147-158, 2003.
23. Vinh-Hung V, Cserni G, Burzykowski T, Van de Steene J, Voordeckers M, Storme G: Effect of the number of uninvolved nodes on survival in early breast cancer. Oncol Rep, 10: 363-368, 2003.
24. Vinh-Hung V, Burzykowski T, Cserni G, Voordeckers M, Van de Steene J, Storme G: Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. Int J Oncol, 22: 697-704, 2003.
25. Vinh-Hung V, Verschraegen C, Royce M, Van de Steene J, Tai P, Cserni G, Storme G, Vlastos G: Response re: Breast-conserving surgery with or without radiotherapy: pooled analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst, 96: 1255-1257, 2004.
26. van der Hage JA, Putter H, Bonnema J, Bartelink H, Therasse P, van de Velde CJ: Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis. Eur J Cancer, 39: 2192-2199, 2003.
27. Taylor ME, Haffty BG, Shank BM, Halberg FE, Martinez AA, McCormick B, McNeese MD, Mendenhall NP, Mitchell SE, Rabinovitch RA, Solin LJ, Singletary SE, Leibel S, Recht A: Postmastectomy radiotherapy. American College of Radiology. ACR Appropriateness Criteria. Radiology, 215 Suppl: 1153-1170, 2000.
28. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW, Jr., Whelan TJ, Pfister DG: Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol, 19: 1539-1569, 2001.
29. Shikama N, Nishikawa A, Mitsumori M, Hiraoka M, Yamamoto T, Teshima T, Inoue T, Wilson F, Owen J: Patterns of care study: comparison of process of post-mastectomy radiotherapy (PMRT) in Japan and the USA. Jpn J Clin Oncol, 33: 518-521, 2003.
30. Pierce LJ: Randomized trial of post-mastectomy radiotherapy in stage II breast cancer in women with one to three positive axillary nodes, phase III. SWOG, 2003.